Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structures of the σ2 receptor enable docking for bioactive ligand discovery
Assaf Alon, Jiankun Lyu, João M. Bráz, et al.
Nature (2021) Vol. 600, Iss. 7890, pp. 759-764
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Computational approaches streamlining drug discovery
Anastasiia Sadybekov, Vsevolod Katritch
Nature (2023) Vol. 616, Iss. 7958, pp. 673-685
Open Access | Times Cited: 573
Modeling the expansion of virtual screening libraries
Jiankun Lyu, John J. Irwin, Brian K. Shoichet
Nature Chemical Biology (2023) Vol. 19, Iss. 6, pp. 712-718
Open Access | Times Cited: 116
ZINC-22─A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery
Benjamin I. Tingle, Khanh Tang, Mar Castanon, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 4, pp. 1166-1176
Open Access | Times Cited: 116
Structure-based discovery of nonopioid analgesics acting through the α 2A -adrenergic receptor
Elissa A. Fink, Jun Xu, Harald Hübner, et al.
Science (2022) Vol. 377, Iss. 6614
Open Access | Times Cited: 102
The Art and Science of Molecular Docking
Joseph M. Paggi, Ayush Pandit, Ron O. Dror
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 389-410
Closed Access | Times Cited: 64
AlphaFold2 structures guide prospective ligand discovery
Jiankun Lyu, Nicholas J. Kapolka, Ryan H. Gumpper, et al.
Science (2024) Vol. 384, Iss. 6702
Closed Access | Times Cited: 51
Structure-based discovery of conformationally selective inhibitors of the serotonin transporter
Isha Singh, Anubha Seth, Christian B. Billesbølle, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2160-2175.e17
Open Access | Times Cited: 48
Structure-based virtual screening of vast chemical space as a starting point for drug discovery
Jens Carlsson, Andreas Luttens
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102829-102829
Open Access | Times Cited: 16
The impact of library size and scale of testing on virtual screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
Nature Chemical Biology (2025)
Open Access | Times Cited: 3
“Selective” serotonin 5-HT2A receptor antagonists
Austen B. Casey, Meng Cui, Raymond G. Booth, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115028-115028
Open Access | Times Cited: 53
A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years
Hui Zhu, Yulin Zhang, Wěi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15961-15961
Open Access | Times Cited: 42
Conserved Sites and Recognition Mechanisms of T1R1 and T2R14 Receptors Revealed by Ensemble Docking and Molecular Descriptors and Fingerprints Combined with Machine Learning
Zhiyong Cui, Ninglong Zhang, Tianxing Zhou, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 14, pp. 5630-5645
Closed Access | Times Cited: 38
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Recent Developments in Ultralarge and Structure-Based Virtual Screening Approaches
Christoph Gorgulla
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 229-258
Open Access | Times Cited: 26
Sigma-2 Receptors—From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases
Britney N. Lizama, Jennifer Kahle, Susan M. Catalano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6251-6251
Open Access | Times Cited: 25
Large library docking for novel SARS‐CoV‐2 main protease non‐covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 24
Pareto optimization to accelerate multi-objective virtual screening
Jenna C. Fromer, David Graff, Connor W. Coley
Digital Discovery (2024) Vol. 3, Iss. 3, pp. 467-481
Open Access | Times Cited: 16
Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
Structure-based discovery of CFTR potentiators and inhibitors
Fangyu Liu, Anat Levit, Jesper Levring, et al.
Cell (2024) Vol. 187, Iss. 14, pp. 3712-3725.e34
Open Access | Times Cited: 13
The Science and Art of Structure-Based Virtual Screening
Hongtao Zhao
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 436-440
Closed Access | Times Cited: 9
TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy
Aida Marcotti, Jorge Fernández‐Trillo, Alejandro González, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 475-491
Open Access | Times Cited: 37
Towards Structure-Guided Development of Pain Therapeutics Targeting Voltage-Gated Sodium Channels
Phuong T. Nguyen, Vladimir Yarov‐Yarovoy
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Prioritizing Virtual Screening with Interpretable Interaction Fingerprints
Alexandre Victor Fassio, Laura Shub, Luca Ponzoni, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 18, pp. 4300-4318
Open Access | Times Cited: 29
Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screening
Jacqueline Kuan, Mariia Radaeva, Adeline Avenido, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 19
VirtualFlow 2.0 - The Next Generation Drug Discovery Platform Enabling Adaptive Screens of 69 Billion Molecules
Christoph Gorgulla, AkshatKumar Nigam, Matt Koop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top